Correlation Between Ascletis Pharma and Intelgenx Technologs

Can any of the company-specific risk be diversified away by investing in both Ascletis Pharma and Intelgenx Technologs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ascletis Pharma and Intelgenx Technologs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ascletis Pharma and Intelgenx Technologs, you can compare the effects of market volatilities on Ascletis Pharma and Intelgenx Technologs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ascletis Pharma with a short position of Intelgenx Technologs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ascletis Pharma and Intelgenx Technologs.

Diversification Opportunities for Ascletis Pharma and Intelgenx Technologs

0.0

Correlation Coefficient

Ascletis Pharma  Intelgenx Technologs

Pay attention - limited upside

The 3 months correlation between Ascletis and Intelgenx is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Ascletis Pharma and Intelgenx Technologs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intelgenx Technologs and Ascletis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ascletis Pharma are associated (or correlated) with Intelgenx Technologs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intelgenx Technologs has no effect on the direction of Ascletis Pharma i.e., Ascletis Pharma and Intelgenx Technologs go up and down completely randomly.

Pair Corralation between Ascletis Pharma and Intelgenx Technologs

Assuming the 90 days horizon Ascletis Pharma is expected to under-perform the Intelgenx Technologs. But the pink sheet apears to be less risky and, when comparing its historical volatility, Ascletis Pharma is 1.21 times less risky than Intelgenx Technologs. The pink sheet trades about -0.01 of its potential returns per unit of risk. The Intelgenx Technologs is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  12.00  in Intelgenx Technologs on September 18, 2024 and sell it today you would earn a total of  5.00  from holding Intelgenx Technologs or generate 41.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	99.8%
Values	Daily Returns

Ascletis Pharma  vs.  Intelgenx Technologs

Ascletis Pharma

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Ascletis Pharma are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak essential indicators, Ascletis Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

Intelgenx Technologs

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Intelgenx Technologs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Intelgenx Technologs is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Ascletis Pharma and Intelgenx Technologs

The main advantage of trading using opposite Ascletis Pharma and Intelgenx Technologs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ascletis Pharma position performs unexpectedly, Intelgenx Technologs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intelgenx Technologs will offset losses from the drop in Intelgenx Technologs' long position.

The idea behind Ascletis Pharma and Intelgenx Technologs pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.